SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,224 | +22.4% | 1,407 | 0.0% | 0.00% | – |
| Q1 2023 | $1,000 | +99900.0% | 1,407 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 1,407 | -62.6% | 0.00% | – |
| Q3 2022 | $4,000 | +100.0% | 3,758 | +181.5% | 0.00% | – |
| Q2 2022 | $2,000 | -96.9% | 1,335 | -94.0% | 0.00% | – |
| Q1 2022 | $65,000 | -22.6% | 22,082 | +26.4% | 0.00% | – |
| Q4 2021 | $84,000 | -34.4% | 17,471 | +3.5% | 0.00% | – |
| Q3 2021 | $128,000 | +13.3% | 16,873 | +11.0% | 0.00% | – |
| Q2 2021 | $113,000 | +3666.7% | 15,200 | +3700.0% | 0.00% | – |
| Q1 2021 | $3,000 | -97.4% | 400 | -97.7% | 0.00% | – |
| Q3 2020 | $115,000 | – | 17,719 | +160981.8% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 11 | -99.8% | 0.00% | – |
| Q2 2019 | $14,000 | +7.7% | 5,054 | +83.2% | 0.00% | – |
| Q1 2019 | $13,000 | -88.2% | 2,758 | -89.4% | 0.00% | – |
| Q4 2018 | $110,000 | +511.1% | 25,922 | +1440.2% | 0.00% | – |
| Q3 2018 | $18,000 | -25.0% | 1,683 | +14.0% | 0.00% | – |
| Q2 2018 | $24,000 | – | 1,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
| SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
| Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
| ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
| Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
| Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
| HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |